<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28479621</article-id><article-id pub-id-type="pmc">5407251</article-id><article-id pub-id-type="publisher-id">BLT.16.178327</article-id><article-id pub-id-type="doi">10.2471/BLT.16.178327</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Increased immunization coverage addresses the equity gap in Nepal</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Une meilleure couverture vaccinale pour combler le foss&#x000e9; en mati&#x000e8;re d'&#x000e9;quit&#x000e9; au N&#x000e9;pal</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">El aumento de la cobertura de inmunizaci&#x000f3;n aborda la brecha de equidad en Nepal</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00627;&#x00644;&#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00632;&#x00627;&#x0064a;&#x0062f;&#x00629; &#x00644;&#x00644;&#x0062a;&#x00645;&#x00646;&#x0064a;&#x00639; &#x0062a;&#x00639;&#x00627;&#x00644;&#x0062c; &#x00627;&#x00644;&#x00641;&#x0062c;&#x00648;&#x00629; &#x00641;&#x0064a;&#x000a0;&#x00627;&#x00644;&#x00625;&#x00646;&#x00635;&#x00627;&#x00641;&#x000a0;&#x00628;&#x00646;&#x0064a;&#x00628;&#x00627;&#x00644; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x05c3c;&#x06cca;&#x05c14;&#x0514d;&#x075ab;&#x08986;&#x076d6;&#x07387;&#x07684;&#x063d0;&#x09ad8;&#x07f29;&#x05c0f;&#x04e86;&#x05e73;&#x07b49;&#x06027;&#x05dee;&#x08ddd;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00421;&#x0043d;&#x00438;&#x00436;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x0044f; &#x0043d;&#x00435;&#x00440;&#x00430;&#x00432;&#x00435;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00430; &#x00437;&#x00430; &#x00441;&#x00447;&#x00435;&#x00442; &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00448;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x0044f; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442;&#x00430; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00435;&#x00439; &#x00432; &#x0041d;&#x00435;&#x0043f;&#x00430;&#x0043b;&#x00435;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Ashish KC et al.</alt-title><alt-title alt-title-type="title-running-head">Equity distribution of immunization coverage in Nepal</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>KC</surname><given-names>Ashish</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nelin</surname><given-names>Viktoria</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Raaijmakers</surname><given-names>Hendrikus</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyung Joon</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Chahana</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>M&#x000e5;lqvist</surname><given-names>Mats</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><label>a</label>United Nations Children&#x02019;s Fund, Nepal Country Office, PO Box 1187, UN House, Pulchowk, Lalitpur, Kathmandu, <country>Nepal</country>.</aff><aff id="aff2"><label>b</label>Department of Women&#x02019;s and Children&#x02019;s Health, Uppsala University, Uppsala, <country>Sweden</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Ashish KC (email: <email xlink:href="akc@unicef.org">akc@unicef.org</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>02</day><month>2</month><year>2017</year></pub-date><volume>95</volume><issue>4</issue><fpage>261</fpage><lpage>269</lpage><history><date date-type="received"><day>29</day><month>5</month><year>2016</year></date><date date-type="rev-recd"><day>05</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>08</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>(c) 2017 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To compare immunization coverage and equity distribution of coverage between 2001 and 2014 in Nepal.</p></sec><sec><title>Methods</title><p>We used data from the Demographic and Health Surveys carried out in 2001, 2006 and 2011 together with data from the 2014 Multiple Indicator Cluster Survey. We calculated the proportion, in mean percentage, of children who had received bacille Calmette&#x02013;Gu&#x000e9;rin (BCG) vaccine, three doses of polio vaccine, three doses of diphtheria&#x02013;pertussis&#x02013;tetanus (DPT) vaccine and measles vaccine. To measure inequities between wealth quintiles, we calculated the slope index of inequality (SII) and relative index of inequality (RII) for all surveys.</p></sec><sec><title>Findings</title><p>From 2001 to 2014, the proportion of children who received all vaccines at the age of 12&#x000a0;months increased from 68.8% (95% confidence interval, CI: 67.5&#x02013;70.1) to 82.4% (95% CI: 80.7&#x02013;84.0). While coverage of BCG, DPT and measles immunization statistically increased during the study period, the proportion of children who received the third dose of polio vaccine decreased from 93.3% (95% CI: 92.7&#x02013;93.9) to 88.1% (95% CI: 86.8&#x02013;89.3). The poorest wealth quintile showed the greatest improvement in immunization coverage, from 58% to 77.9%, while the wealthiest quintile only improved from 84.8% to 86.0%. The SII for children who received all vaccines improved from 0.070 (95% CI: 0.061&#x02013;0.078) to 0.026 (95% CI: 0.013&#x02013;0.039) and RII improved from 1.13 to 1.03.</p></sec><sec><title>Conclusion</title><p>The improvement in immunization coverage between 2001 and 2014 in Nepal can mainly be attributed to the interventions targeting the disadvantaged populations.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>Comparer la couverture vaccinale et la r&#x000e9;partition &#x000e9;quitable de la couverture entre&#x000a0;2001 et&#x000a0;2014 au N&#x000e9;pal.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons utilis&#x000e9; des donn&#x000e9;es provenant d'enqu&#x000ea;tes d&#x000e9;mographiques et sanitaires r&#x000e9;alis&#x000e9;es en&#x000a0;2001,&#x000a0;2006 et&#x000a0;2011, ainsi que des donn&#x000e9;es tir&#x000e9;es d'une enqu&#x000ea;te par grappes &#x000e0; indicateurs multiples men&#x000e9;e en&#x000a0;2014. Nous avons calcul&#x000e9; la proportion, en pourcentage moyen, d'enfants ayant re&#x000e7;u le vaccin bili&#x000e9; de Calmette et Gu&#x000e9;rin (BCG), les trois doses du vaccin antipoliomy&#x000e9;litique, les trois doses du vaccin contre la dipht&#x000e9;rie, la coqueluche et le t&#x000e9;tanos (DCT) et le vaccin contre la rougeole. Afin de mesurer les in&#x000e9;galit&#x000e9;s entre les diff&#x000e9;rents quintiles de richesse, nous avons calcul&#x000e9; l'indice de pente d'in&#x000e9;galit&#x000e9; (SII) et l'indice relatif d'in&#x000e9;galit&#x000e9; (RII) dans le cadre de toutes les enqu&#x000ea;tes.</p></sec><sec><title>R&#x000e9;sultats</title><p>De&#x000a0;2001 &#x000e0;&#x000a0;2014, la proportion d'enfants ayant re&#x000e7;u tous les vaccins &#x000e0; l'&#x000e2;ge de 12&#x000a0;mois est pass&#x000e9;e de&#x000a0;68,8% (intervalle de confiance, IC, &#x000e0;&#x000a0;95%: 67,5&#x02013;70,1) &#x000e0;&#x000a0;82,4% (IC &#x000e0;&#x000a0;95%: 80,7&#x02013;84,0). Si la couverture des vaccins BCG, DCT et contre la rougeole a statistiquement augment&#x000e9; au cours de la p&#x000e9;riode &#x000e9;tudi&#x000e9;e, la proportion d'enfants ayant re&#x000e7;u la troisi&#x000e8;me dose du vaccin antipoliomy&#x000e9;litique a diminu&#x000e9; de&#x000a0;93,3% (IC &#x000e0;&#x000a0;95%: 92,7&#x02013;93,9) &#x000e0;&#x000a0;88,1% (IC &#x000e0;&#x000a0;95%: 86,8&#x02013;89,3). L'am&#x000e9;lioration la plus importante en mati&#x000e8;re de couverture vaccinale a &#x000e9;t&#x000e9; observ&#x000e9;e au sein du quintile de richesse le plus bas (de&#x000a0;58% &#x000e0;&#x000a0;77,9%), le quintile le plus riche connaissant seulement une am&#x000e9;lioration de&#x000a0;84,8% &#x000e0;&#x000a0;86,0%. Dans le cas des enfants ayant re&#x000e7;u tous les vaccins, le SII est pass&#x000e9; de&#x000a0;0,070 (IC &#x000e0;&#x000a0;95%: 0,061&#x02013;0,078) &#x000e0;&#x000a0;0,026 (IC &#x000e0;&#x000a0;95%: 0,013&#x02013;0,039) et le RII de&#x000a0;1,13 &#x000e0;&#x000a0;1,03.</p></sec><sec><title>Conclusion</title><p>L'am&#x000e9;lioration de la couverture vaccinale entre&#x000a0;2001&#x000a0;et&#x000a0;2014 au N&#x000e9;pal r&#x000e9;sulte essentiellement des interventions ciblant les populations d&#x000e9;favoris&#x000e9;es</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Comparar la cobertura de inmunizaci&#x000f3;n y la distribuci&#x000f3;n de la equidad de cobertura entre 2001 y 2014 en Nepal.</p></sec><sec><title>M&#x000e9;todos</title><p>Se utilizaron datos de las Encuestas de Demograf&#x000ed;a y Salud realizadas en 2001, 2006 y 2011, junto con datos de la Encuesta de Conglomerados de Indicadores M&#x000fa;ltiples de 2014. Se calcul&#x000f3; la proporci&#x000f3;n (en porcentaje medio) de ni&#x000f1;os que hab&#x000ed;an recibido la vacuna del bacilo de Calmette-Gu&#x000e9;rin (BCG), tres dosis de la vacuna antipoliomiel&#x000ed;tica, tres dosis de la vacuna contra la difteria, la tos ferina y el t&#x000e9;tanos (DPT) y la vacuna contra el sarampi&#x000f3;n. Para medir la falta de equidad entre los quintiles de riqueza, se calcularon el &#x000ed;ndice de desigualdad de la pendiente (IDP) y el &#x000ed;ndice relativo de desigualdad (IRD) en todas las encuestas.</p></sec><sec><title>Resultados</title><p>De 2001 a 2014, el porcentaje de ni&#x000f1;os que recibieron todas las vacunas a la edad de 12 meses aument&#x000f3; de un 68,8% (intervalo de confianza, IC, del 95%: 67,5&#x02013;70,1) a un 82,4% (IC del 95%: 80,7&#x02013;84,0). Estad&#x000ed;sticamente, si bien la cobertura de inmunizaci&#x000f3;n contra BGC, DPT y sarampi&#x000f3;n aument&#x000f3; durante el periodo de estudio, el porcentaje de ni&#x000f1;os que recibieron la tercera dosis de la vacuna antipoliomiel&#x000ed;tica descendi&#x000f3; de un 93,3% (IC del 95%: 92,7&#x02013;93,9) a un 88,1% (IC del 95%: 86,8&#x02013;89,3). El quintil de riqueza m&#x000e1;s pobre fue el que mostr&#x000f3; la mayor mejora en la cobertura de inmunizaci&#x000f3;n, de un 58% a un 77,9%, mientras que el m&#x000e1;s rico mejor&#x000f3; &#x000fa;nicamente de un 84,8% a un 86,0%. El IDP para los ni&#x000f1;os que recibieron todas las vacunas aument&#x000f3; de un 0,070 (IC del 95%: 0,061-0,078) a un 0,026 (IC del 95%: 0,013&#x02013;0,039) y el IRD aument&#x000f3; de un 1,13 a un 1,03.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>La mejora de la cobertura de inmunizaci&#x000f3;n entre 2001 y 2014 en Nepal puede atribuirse principalmente a las intervenciones orientadas a los sectores demogr&#x000e1;ficos desfavorecidos.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629; &#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00645;&#x00646;&#x0064a;&#x00639; &#x00648;&#x0062a;&#x00648;&#x00632;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00625;&#x00646;&#x00635;&#x00627;&#x00641; &#x00641;&#x0064a; &#x0062e;&#x0062f;&#x00645;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00627; &#x00628;&#x0064a;&#x00646; &#x00639;&#x00627;&#x00645;&#x0064a;&#x00651; 2001 &#x00648;2014 &#x00641;&#x0064a; &#x00646;&#x0064a;&#x00628;&#x00627;&#x00644;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00645;&#x00646;&#x00627; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x0062e;&#x00631;&#x0062c;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x00648;&#x0062d; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0064a;&#x00645;&#x00648;&#x0063a;&#x00631;&#x00627;&#x00641;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645;&#x0062a; &#x00641;&#x0064a; &#x00633;&#x00646;&#x00648;&#x00627;&#x0062a; 2001&#x0060c; &#x00648;2006&#x0060c; &#x00648;2011 &#x00645;&#x00639; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x0062e;&#x00631;&#x0062c;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x00648;&#x0062d; &#x00627;&#x00644;&#x00639;&#x00646;&#x00642;&#x00648;&#x0062f;&#x0064a;&#x00629; &#x00645;&#x0062a;&#x00639;&#x0062f;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x00624;&#x00634;&#x00631;&#x00627;&#x0062a;. &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062d;&#x00633;&#x00627;&#x00628; &#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00645;&#x00626;&#x00648;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0062a;&#x00644;&#x00642;&#x00648;&#x00627; &#x00644;&#x00642;&#x00627;&#x0062d; &#x00639;&#x00635;&#x0064a;&#x00627;&#x0062a; &#x00643;&#x00627;&#x00644;&#x00645;&#x0064a;&#x0062a; &#x0063a;&#x0064a;&#x00631;&#x00627;&#x00646; (BCG)&#x0060c; &#x00648;&#x0062b;&#x00644;&#x00627;&#x0062b; &#x0062c;&#x00631;&#x00639;&#x00627;&#x0062a; &#x00645;&#x00646; &#x00644;&#x00642;&#x00627;&#x0062d; &#x00634;&#x00644;&#x00644; &#x00627;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644;&#x0060c; &#x00648;&#x0062b;&#x00644;&#x00627;&#x0062b; &#x0062c;&#x00631;&#x00639;&#x00627;&#x0062a; &#x00645;&#x00646; &#x00644;&#x00642;&#x00627;&#x0062d; &#x00627;&#x00644;&#x0062f;&#x00641;&#x0062a;&#x00631;&#x0064a;&#x00627; &#x00648;&#x00627;&#x00644;&#x00633;&#x00639;&#x00627;&#x00644; &#x00627;&#x00644;&#x0062f;&#x0064a;&#x00643;&#x0064a; &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a;&#x0062a;&#x00627;&#x00646;&#x00648;&#x00633; (&#x00627;&#x00644;&#x00644;&#x00642;&#x00627;&#x0062d; &#x00627;&#x00644;&#x0062b;&#x00644;&#x00627;&#x0062b;&#x0064a;) &#x00648;&#x00644;&#x00642;&#x00627;&#x0062d; &#x00627;&#x00644;&#x0062d;&#x00635;&#x00628;&#x00629;. &#x00648;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00628; &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x00641;&#x00627;&#x00648;&#x0062a; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00641;&#x00626;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00645;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646;&#x0064a;&#x00629;&#x0060c; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062d;&#x00633;&#x00627;&#x00628; &#x00645;&#x00624;&#x00634;&#x00631; &#x00645;&#x00646;&#x0062d;&#x0062f;&#x00631; &#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00648;&#x00627;&#x00629; (SII) &#x00648;&#x00627;&#x00644;&#x00645;&#x00624;&#x00634;&#x00631; &#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x0064a; &#x00644;&#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00648;&#x00627;&#x00629; (RII) &#x00644;&#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00645;&#x00633;&#x00648;&#x0062d;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x00627;&#x00631;&#x0062a;&#x00641;&#x00639;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644; &#x00645;&#x00645;&#x00646; &#x0062a;&#x00644;&#x00642;&#x00648;&#x00627; &#x00627;&#x00644;&#x0062a;&#x00637;&#x00639;&#x0064a;&#x00645;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00639;&#x00645;&#x00631; 12 &#x00634;&#x00647;&#x00631;&#x0064b;&#x00627; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00646; &#x00633;&#x00646;&#x00629; 2001 &#x00625;&#x00644;&#x00649; 2014 &#x00645;&#x00646; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;68.8&#x0200f;% </styled-content>(&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95&#x0200f;%</styled-content>: 67.5 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>70.1) &#x00625;&#x00644;&#x00649; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;82.4&#x0200f;% </styled-content>(&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">95&#x0200f;&#x0200f;%</styled-content>: 80.7 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>84.0). &#x00628;&#x0064a;&#x00646;&#x00645;&#x00627; &#x00627;&#x00631;&#x0062a;&#x00641;&#x00639;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00645;&#x00646;&#x0064a;&#x00639; &#x00644;&#x00639;&#x00635;&#x0064a;&#x00627;&#x0062a; &#x00643;&#x00627;&#x00644;&#x00645;&#x0064a;&#x0062a; &#x0063a;&#x0064a;&#x00631;&#x00627;&#x00646; (BCG)&#x0060c; &#x00648;&#x00627;&#x00644;&#x0062f;&#x00641;&#x0062a;&#x00631;&#x0064a;&#x00627; &#x00648;&#x00627;&#x00644;&#x00633;&#x00639;&#x00627;&#x00644; &#x00627;&#x00644;&#x0062f;&#x0064a;&#x00643;&#x0064a; &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a;&#x0062a;&#x00627;&#x00646;&#x00648;&#x00633; &#x00648;&#x00627;&#x00644;&#x0062d;&#x00635;&#x00628;&#x00629; &#x00625;&#x0062d;&#x00635;&#x00627;&#x00626;&#x0064a;&#x0064b;&#x00627; &#x0062e;&#x00644;&#x00627;&#x00644; &#x00641;&#x0062a;&#x00631;&#x00629; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;&#x0060c; &#x00641;&#x00642;&#x0062f; &#x00627;&#x00646;&#x0062e;&#x00641;&#x00636;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644; &#x00645;&#x00645;&#x00646; &#x0062a;&#x00644;&#x00642;&#x00648;&#x00627; &#x0062c;&#x00631;&#x00639;&#x00629; &#x0062a;&#x00637;&#x00639;&#x0064a;&#x00645; &#x00634;&#x00644;&#x00644; &#x00627;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644; &#x00645;&#x00646; <styled-content style-type="direction" style="direction:ltr;">93.3&#x0200f;&#x0200f;% </styled-content>(&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95&#x0200f;%</styled-content>: 92.7 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>93.9) &#x00625;&#x00644;&#x00649; <styled-content style-type="direction" style="direction:ltr;">88.1&#x0200f;&#x0200f;% </styled-content>(&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">95&#x0200f;&#x0200f;%</styled-content>: 86.8 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>89.3). &#x00648;&#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00626;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00645;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00641;&#x00642;&#x0064a;&#x00631;&#x00629; &#x0062a;&#x0062d;&#x00633;&#x00646;&#x0064b;&#x00627; &#x00643;&#x00628;&#x0064a;&#x00631;&#x0064b;&#x00627; &#x00641;&#x0064a; &#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00645;&#x00646;&#x0064a;&#x00639; &#x00645;&#x00646; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;58&#x0200f;% </styled-content>&#x00625;&#x00644;&#x00649; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;77.9&#x0200f;%</styled-content>&#x0060c; &#x00628;&#x0064a;&#x00646;&#x00645;&#x00627; &#x0062a;&#x0062d;&#x00633;&#x00646;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00626;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00645;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0063a;&#x00646;&#x0064a;&#x00629; &#x00645;&#x00646; <styled-content style-type="direction" style="direction:ltr;">84.8&#x0200f;&#x0200f;% </styled-content>&#x00625;&#x00644;&#x00649; <styled-content style-type="direction" style="direction:ltr;">86.0&#x0200f;&#x0200f;% </styled-content>&#x00641;&#x00642;&#x00637;. &#x00648;&#x0062a;&#x0062d;&#x00633;&#x00646; &#x00645;&#x00624;&#x00634;&#x00631; &#x00645;&#x00646;&#x0062d;&#x0062f;&#x00631; &#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00648;&#x00627;&#x00629; &#x00644;&#x00644;&#x00623;&#x00637;&#x00641;&#x00627;&#x00644; &#x00645;&#x00645;&#x00646; &#x0062a;&#x00644;&#x00642;&#x00648;&#x00627; &#x00627;&#x00644;&#x0062a;&#x00637;&#x00639;&#x0064a;&#x00645;&#x00627;&#x0062a; &#x00645;&#x00646; 0.070 (&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">95&#x0200f;&#x0200f;%</styled-content>: 0.061 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>0.078) &#x00625;&#x00644;&#x00649; 0.026 (&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x0064a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95&#x0200f;&#x0200f;%</styled-content>: 0.013 <styled-content style-type="direction" style="direction:ltr;">&#x02013; </styled-content>0.039) &#x00648;&#x0062a;&#x0062d;&#x00633;&#x00646; &#x00627;&#x00644;&#x00645;&#x00624;&#x00634;&#x00631; &#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x0064a; &#x00644;&#x00639;&#x0062f;&#x00645; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00648;&#x00627;&#x00629; &#x00645;&#x00646; 1.13 &#x00625;&#x00644;&#x00649; 1.03. </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x0064a;&#x00645;&#x00643;&#x00646; &#x00625;&#x00631;&#x0062c;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00633;&#x00646; &#x00641;&#x0064a; &#x0062a;&#x0063a;&#x00637;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00645;&#x00646;&#x0064a;&#x00639; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00646; 2001 &#x00648;2014 &#x00625;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00633;&#x0062a;&#x00647;&#x0062f;&#x00641; &#x00627;&#x00644;&#x00642;&#x00637;&#x00627;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062d;&#x00631;&#x00648;&#x00645;&#x00629;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x065e8;&#x05728;&#x06bd4;&#x08f83;&#x000a0;2001&#x000a0;&#x05e74;&#x081f3;&#x000a0;2014&#x000a0;&#x05e74;&#x095f4;&#x05c3c;&#x06cca;&#x05c14;&#x07684;&#x0514d;&#x075ab;&#x08986;&#x076d6;&#x07387;&#x0548c;&#x08986;&#x076d6;&#x07387;&#x05206;&#x05e03;&#x05e73;&#x07b49;&#x06027;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x06211;&#x04eec;&#x091c7;&#x07528;&#x000a0;2001&#x000a0;&#x05e74;&#x03001;2006&#x000a0;&#x05e74;&#x0548c;&#x000a0;2011&#x000a0;&#x05e74;&#x05f00;&#x05c55;&#x07684;&#x04eba;&#x053e3;&#x05065;&#x05eb7;&#x08c03;&#x067e5;&#x07684;&#x06570;&#x0636e;&#x0ff0c;&#x04ee5;&#x053ca;&#x000a0;2014&#x000a0;&#x05e74;&#x0591a;&#x06307;&#x06807;&#x07fa4;&#x04f53;&#x08c03;&#x067e5;&#x07684;&#x06570;&#x0636e;&#x03002; &#x06211;&#x04eec;&#x08ba1;&#x07b97;&#x04e86;&#x063a5;&#x053d7;&#x05361;&#x04ecb;&#x082d7; (BCG)&#x03001;&#x04e09;&#x05242;&#x0810a;&#x09ad3;&#x07070;&#x08d28;&#x0708e;&#x075ab;&#x082d7;&#x03001;&#x04e09;&#x05242;&#x0767e;&#x0767d;&#x07834; (DPT) &#x075ab;&#x082d7;&#x0548c;&#x09ebb;&#x075b9;&#x075ab;&#x082d7;&#x07684;&#x0513f;&#x07ae5;&#x06bd4;&#x04f8b;&#x0ff08;&#x05373;&#x05e73;&#x05747;&#x0767e;&#x05206;&#x06bd4;&#x0ff09;&#x03002; &#x04e3a;&#x04e86;&#x08861;&#x091cf;&#x08d22;&#x05bcc;&#x04e94;&#x05206;&#x04f4d;&#x04eba;&#x07fa4;&#x04e4b;&#x095f4;&#x07684;&#x04e0d;&#x05e73;&#x07b49;&#x06027;&#x0ff0c;&#x06211;&#x04eec;&#x08ba1;&#x07b97;&#x04e86;&#x06240;&#x06709;&#x08c03;&#x067e5;&#x07684;&#x04e0d;&#x05e73;&#x07b49;&#x0659c;&#x07387;&#x06307;&#x06570; (SII) &#x0548c;&#x04e0d;&#x05e73;&#x07b49;&#x076f8;&#x05bf9;&#x06307;&#x06570; (RII)&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x04ece;&#x000a0;2001 &#x05e74;&#x081f3;&#x000a0;2014&#x000a0;&#x05e74;&#x0ff0c;&#x05728;&#x000a0;12&#x000a0;&#x04e2a;&#x06708;&#x05927;&#x065f6;&#x063a5;&#x053d7;&#x05168;&#x090e8;&#x075ab;&#x082d7;&#x07684;&#x0513f;&#x07ae5;&#x06bd4;&#x04f8b;&#x04ece;&#x000a0;68.8%&#x0ff08;95% &#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff0c;CI&#x0ff1a; 67.5&#x02013;70.1&#x0ff09;&#x063d0;&#x09ad8;&#x081f3;&#x000a0;82.4%&#x0ff08;95% CI&#x0ff1a; 80.7&#x02013;84.0)&#x03002; &#x0867d;&#x07136;&#x05361;&#x04ecb;&#x082d7; (BCG)&#x03001;&#x0767e;&#x0767d;&#x07834; (DPT) &#x0548c;&#x09ebb;&#x075b9;&#x07684;&#x0514d;&#x075ab;&#x07edf;&#x08ba1;&#x06570;&#x0636e;&#x05728;&#x07814;&#x07a76;&#x0671f;&#x095f4;&#x06709;&#x06240;&#x063d0;&#x09ad8;&#x0ff0c;&#x04f46;&#x063a5;&#x053d7;&#x07b2c;&#x04e09;&#x05242;&#x0810a;&#x09ad3;&#x07070;&#x08d28;&#x0708e;&#x075ab;&#x082d7;&#x07684;&#x0513f;&#x07ae5;&#x06bd4;&#x04f8b;&#x04ece;&#x000a0;93.3%&#x000a0;(95% CI: 92.7&#x02013;93.9) &#x0964d;&#x04f4e;&#x081f3;&#x000a0;88.1%&#x000a0;(95% CI: 86.8&#x02013;89.3)&#x03002; &#x08d22;&#x05bcc;&#x04e94;&#x05206;&#x04f4d;&#x04e2d;&#x06700;&#x08d2b;&#x07a77;&#x04eba;&#x053e3;&#x07684;&#x0514d;&#x075ab;&#x08986;&#x076d6;&#x07387;&#x07684;&#x063d0;&#x05347;&#x06700;&#x04e3a;&#x0663e;&#x08457;&#x0ff0c;&#x05373;&#x0ff0c;&#x04ece;&#x000a0;58%&#x000a0;&#x081f3;&#x000a0;77.9%&#x03002;&#x0800c;&#x08d22;&#x05bcc;&#x04e94;&#x05206;&#x04f4d;&#x04e2d;&#x06700;&#x05bcc;&#x06709;&#x04eba;&#x053e3;&#x04ec5;&#x07531;&#x000a0;84.8%&#x000a0;&#x063d0;&#x05347;&#x081f3;&#x000a0;86.0%&#x03002; &#x063a5;&#x053d7;&#x05168;&#x090e8;&#x075ab;&#x082d7;&#x07684;&#x0513f;&#x07ae5;&#x07684;&#x04e0d;&#x05e73;&#x07b49;&#x0659c;&#x07387;&#x06307;&#x06570; (SII) &#x04ece;&#x000a0;0.070&#x000a0;(95% CI: 0.061&#x02013;0.078)&#x000a0;&#x063d0;&#x09ad8;&#x081f3;&#x000a0;0.026&#x000a0;(95% CI: 0.013&#x02013;0.039)&#x0ff0c;&#x04e0d;&#x05e73;&#x07b49;&#x076f8;&#x05bf9;&#x06307;&#x06570; (RII) &#x04ece;&#x000a0;1.13&#x000a0;&#x063d0;&#x09ad8;&#x081f3;&#x000a0;1.03&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>2001&#x000a0;&#x05e74;&#x081f3;&#x000a0;2014&#x000a0;&#x05e74;&#x05c3c;&#x06cca;&#x05c14;&#x0514d;&#x075ab;&#x08986;&#x076d6;&#x07387;&#x07684;&#x063d0;&#x09ad8;&#x04e3b;&#x08981;&#x05f52;&#x0529f;&#x04e8e;&#x09488;&#x05bf9;&#x05f31;&#x052bf;&#x07fa4;&#x04f53;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00441;&#x00442;&#x00438; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x0044f; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442;&#x00430; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00435;&#x00439; &#x00438; &#x00440;&#x00430;&#x00432;&#x0043d;&#x0043e;&#x0043c;&#x00435;&#x00440;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442;&#x00430; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; 2001 &#x00438; 2014&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;&#x0043c;&#x00438; &#x00432; &#x0041d;&#x00435;&#x0043f;&#x00430;&#x0043b;&#x00435;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00434;&#x00435;&#x0043c;&#x0043e;&#x00433;&#x00440;&#x00430;&#x00444;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00432; &#x0043e;&#x00431;&#x0043b;&#x00430;&#x00441;&#x00442;&#x00438; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;, &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; 2001, 2006 &#x00438; 2011&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;&#x00445;, &#x00432;&#x0043c;&#x00435;&#x00441;&#x00442;&#x00435; &#x00441; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x0043a;&#x0043b;&#x00430;&#x00441;&#x00442;&#x00435;&#x00440;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043e;&#x00431;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; 2014&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430; &#x00441;&#x0043e; &#x0043c;&#x0043d;&#x0043e;&#x00436;&#x00435;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044f;&#x0043c;&#x00438;. &#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00440;&#x00430;&#x00441;&#x00441;&#x00447;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438; &#x0043f;&#x00440;&#x0043e;&#x0043f;&#x0043e;&#x00440;&#x00446;&#x00438;&#x0044e; &#x00432; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00435;&#x0043c; &#x0043f;&#x00440;&#x0043e;&#x00446;&#x00435;&#x0043d;&#x00442;&#x0043d;&#x0043e;&#x0043c; &#x00437;&#x0043d;&#x00430;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00434;&#x00435;&#x00442;&#x00435;&#x00439;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x0043c; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x00432;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00430; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;&#x000a0;(&#x00431;&#x00430;&#x00446;&#x00438;&#x0043b;&#x0043b;&#x00430; &#x0041a;&#x00430;&#x0043b;&#x0044c;&#x0043c;&#x00435;&#x00442;&#x00442;&#x00430;-&#x00413;&#x00435;&#x00440;&#x00435;&#x0043d;&#x00430; (&#x00411;&#x00426;&#x00416;)), &#x00442;&#x00440;&#x00438; &#x00434;&#x0043e;&#x00437;&#x0044b; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x0043e;&#x0043c;&#x00438;&#x00435;&#x0043b;&#x00438;&#x00442;&#x00430;, &#x00442;&#x00440;&#x00438; &#x00434;&#x0043e;&#x00437;&#x0044b; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x00434;&#x00438;&#x00444;&#x00442;&#x00435;&#x00440;&#x00438;&#x00438;, &#x0043a;&#x0043e;&#x0043a;&#x0043b;&#x0044e;&#x00448;&#x00430;, &#x00441;&#x00442;&#x0043e;&#x0043b;&#x00431;&#x0043d;&#x0044f;&#x0043a;&#x00430;&#x000a0;(&#x00410;&#x0041a;&#x00414;&#x00421;) &#x00438; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x0043a;&#x0043e;&#x00440;&#x00438;. &#x00427;&#x00442;&#x0043e;&#x00431;&#x0044b; &#x00438;&#x00437;&#x0043c;&#x00435;&#x00440;&#x00438;&#x00442;&#x0044c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043d;&#x0044c; &#x0043d;&#x00435;&#x00440;&#x00430;&#x00432;&#x00435;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00430; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x0043a;&#x00432;&#x00438;&#x0043d;&#x00442;&#x00438;&#x0043b;&#x0044f;&#x0043c;&#x00438; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430;, &#x00434;&#x0043b;&#x0044f; &#x00432;&#x00441;&#x00435;&#x00445; &#x0043e;&#x00431;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00431;&#x0044b;&#x0043b; &#x00440;&#x00430;&#x00441;&#x00441;&#x00447;&#x00438;&#x00442;&#x00430;&#x0043d; &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441; &#x0043d;&#x00430;&#x0043a;&#x0043b;&#x0043e;&#x0043d;&#x00430; &#x0043d;&#x00435;&#x00440;&#x00430;&#x00432;&#x00435;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00430;&#x000a0;(slope index of inequality, SII) &#x00438; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441; &#x0043d;&#x00435;&#x00440;&#x00430;&#x00432;&#x00435;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00430;&#x000a0;(relative index of inequality, RII).</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00421; 2001 &#x0043f;&#x0043e; 2014&#x000a0;&#x00433;&#x0043e;&#x00434; &#x00434;&#x0043e;&#x0043b;&#x0044f; &#x00434;&#x00435;&#x00442;&#x00435;&#x00439;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x00432;&#x00448;&#x00438;&#x00445; &#x00432;&#x00441;&#x00435; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b; &#x00432; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00435; 12&#x000a0;&#x0043c;&#x00435;&#x00441;&#x0044f;&#x00446;&#x00435;&#x00432;, &#x00443;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00438;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00441; 68,8%&#x000a0;(95%-&#x00439; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;, &#x00414;&#x00418;: 67,5&#x02013;70,1) &#x00434;&#x0043e; 82,4%&#x000a0;(95%-&#x00439; &#x00414;&#x00418;: 80,7&#x02013;84,0). &#x00412; &#x00442;&#x0043e; &#x00432;&#x00440;&#x00435;&#x0043c;&#x0044f; &#x0043a;&#x00430;&#x0043a; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442; &#x00411;&#x00426;&#x00416;, &#x00410;&#x0041a;&#x00414;&#x00421; &#x00438; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00435;&#x00439; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x0043a;&#x0043e;&#x00440;&#x00438; &#x00441;&#x00442;&#x00430;&#x00442;&#x00438;&#x00441;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438; &#x00443;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00438;&#x0043b;&#x00441;&#x0044f; &#x00432; &#x00442;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434;&#x00430; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x00434;&#x0043e;&#x0043b;&#x0044f; &#x00434;&#x00435;&#x00442;&#x00435;&#x00439;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x00432;&#x00448;&#x00438;&#x00445; &#x00442;&#x00440;&#x00435;&#x00442;&#x0044c;&#x0044e; &#x00434;&#x0043e;&#x00437;&#x00443; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x0043f;&#x0043e;&#x0043b;&#x00438;&#x0043e;&#x0043c;&#x00438;&#x00435;&#x0043b;&#x00438;&#x00442;&#x00430;, &#x00443;&#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00438;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00441; 93,3%&#x000a0;(95%-&#x00439; &#x00414;&#x00418;: 92,7&#x02013;93,9) &#x00434;&#x0043e; 88,1%&#x000a0;(95%-&#x00439; &#x00414;&#x00418;: 86,8&#x02013;89,3). &#x00412; &#x00431;&#x00435;&#x00434;&#x0043d;&#x00435;&#x00439;&#x00448;&#x00435;&#x0043c; &#x0043a;&#x00432;&#x00438;&#x0043d;&#x00442;&#x00438;&#x0043b;&#x00435; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00438;&#x00437;&#x0043e;&#x00448;&#x0043b;&#x0043e; &#x0043d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00435;&#x00435; &#x00443;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442;&#x00430; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00435;&#x00439;&#x000a0;&#x02014; &#x00441; 58 &#x00434;&#x0043e; 77,9%, &#x00432; &#x00442;&#x0043e; &#x00432;&#x00440;&#x00435;&#x0043c;&#x0044f; &#x0043a;&#x00430;&#x0043a; &#x00432; &#x0043d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00431;&#x0043e;&#x00433;&#x00430;&#x00442;&#x0043e;&#x0043c; &#x0043a;&#x00432;&#x00438;&#x0043d;&#x00442;&#x00438;&#x0043b;&#x00435; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442; &#x00443;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00438;&#x0043b;&#x00441;&#x0044f; &#x00442;&#x0043e;&#x0043b;&#x0044c;&#x0043a;&#x0043e; &#x00441; 84,8 &#x00434;&#x0043e; 86,0%. &#x00414;&#x0043b;&#x0044f; &#x00434;&#x00435;&#x00442;&#x00435;&#x00439;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00438;&#x0043b;&#x00438; &#x00432;&#x00441;&#x00435; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b;, &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441; SII &#x00438;&#x00437;&#x0043c;&#x00435;&#x0043d;&#x00438;&#x0043b;&#x00441;&#x0044f; &#x00441; 0,070&#x000a0;(95%-&#x00439; &#x00414;&#x00418;: 0,061&#x02013;0,078) &#x00434;&#x0043e; 0,026&#x000a0;(95%-&#x00439; &#x00414;&#x00418;: 0,013&#x02013;0,039), &#x00430; &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441; RII &#x00438;&#x00437;&#x0043c;&#x00435;&#x0043d;&#x00438;&#x0043b;&#x00441;&#x0044f; &#x00441; 1,13 &#x00434;&#x0043e; 1,03.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00423;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043e;&#x00445;&#x00432;&#x00430;&#x00442;&#x00430; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00435;&#x00439; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; 2001 &#x00438; 2014&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;&#x0043c;&#x00438; &#x00432; &#x0041d;&#x00435;&#x0043f;&#x00430;&#x0043b;&#x00435; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00432;&#x00443;&#x0044e; &#x0043e;&#x00447;&#x00435;&#x00440;&#x00435;&#x00434;&#x0044c; &#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x00442;&#x0044c; &#x00441; &#x0043c;&#x00435;&#x00440;&#x0043e;&#x0043f;&#x00440;&#x00438;&#x0044f;&#x00442;&#x00438;&#x0044f;&#x0043c;&#x00438;, &#x0043e;&#x00440;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x0043d;&#x00430; &#x0043c;&#x00430;&#x0043b;&#x0043e;&#x0043e;&#x00431;&#x00435;&#x00441;&#x0043f;&#x00435;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x0044b; &#x0043d;&#x00430;&#x00441;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Immunization is a proven, cost-effective intervention to reduce morbidity and mortality from vaccine-preventable diseases.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Each year immunization averts 2.5 million deaths in children younger than 5&#x000a0;years.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> Globally in 2011, 103 million (83% of total) children received all three doses of diphtheria&#x02013;pertussis&#x02013;tetanus (DPT3) vaccine, but an estimated 22 million children did not complete such vaccination.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Gaps in immunization coverage exist between and within countries, and in some places, the gap is increasing. For example, the average DPT3 coverage in low-income countries was 15 percentage points lower than that of high-income countries in 2011.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="R4" ref-type="bibr"><sup>4</sup></xref></p><p>To reach universal immunization coverage and to increase equity, countries need to focus on targeted interventions that reach the most disadvantaged populations, rather than only focusing on increasing coverage at the national level.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R5" ref-type="bibr"><sup>5</sup></xref> For example, countries with the most rapid increase in overall coverage of measles vaccination also show the greatest improvement in coverage of the population in the poorest wealth quintile.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref></p><p>One intervention to reach disadvantaged populations is by targeted communication, which aims to create a demand for immunization in a population. Communication through community mobilization, where influential local leaders support vaccination, could have a positive influence on the community&#x02019;s trust and willingness to vaccinate their children.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> Which communication intervention to use in hard-to-reach populations to improve immunization coverage has to be based on which vaccination barriers these populations are facing.</p><p>To increase immunization coverage in Nepal, the government has invested in efforts and resources to improve the service delivery system of the national immunization programme.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> During the last two decades, national health policies and a health sector strategy have been implemented to improve coverage and the health and survival of children.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>&#x02013;</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref> One of the main strategic pillars of the <italic>National communication strategy on maternal, newborn, child health 2011&#x02013;2016</italic>, is community mobilization of unvaccinated and under-vaccinated communities to increase coverage.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Furthermore, to increase access to vaccination in geographic areas with low coverage, the government has identified bottlenecks in supply of services and has mobilized local resources to intensify outreach clinics and mobile clinics.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>&#x02013;</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><p>The Nepalese National Immunization Programme, created in 1979, aims to vaccinate all children in the country. The programme is guided by a comprehensive multi-year plan for 2017&#x02013;2022.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> According to this plan, the public sector is the primary provider of immunization services, although the private sector is increasingly providing such services. The government provides all vaccine included in the programme free-of-charge. In 1989, the programme provided immunization services for six vaccine-preventable diseases, which were oral polio vaccine, DPT vaccine, tetanus toxoid, bacille Calmette&#x02013;Gu&#x000e9;rin (BCG) for tuberculosis and measles vaccine. Between 2000 and 2015, the programme introduced six new vaccines: hepatitis B vaccine, <italic>Haemophilus influenza B</italic> vaccine, rubella vaccine, Japanese encephalitis vaccine, injectable polio vaccine and pneumococcal vaccine. In 2015, the programme provided immunization for 11 vaccine-preventable diseases (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>National immunization programme, Nepal, 2015</title></caption><table frame="hsides" rules="groups"><col width="124" span="1"/><col width="83" span="1"/><col width="162" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Vaccine</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of doses</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Age at vaccination</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">BCG</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">At birth</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pentavalent<bold><sup>a</sup></bold></td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">6, 10 and 14 weeks</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Oral polio<bold><sup>b</sup></bold></td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">6, 10 and 14 weeks</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Measles rubella</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">9 and 15 months</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Injectable polio<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">14 weeks</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pneumococcal</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">6 and 10 weeks and 9&#x000a0;months</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Japanese encephalitis</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">12 months</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tetanus toxoid</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">N/A<sup>c</sup></td></tr></tbody></table><table-wrap-foot><p>BCG: bacille Calmette&#x02013;Gu&#x000e9;rin; N/A: not applicable.</p><p><sup>a</sup> Includes diphtheria, pertussis, tetanus, hepatitis B and <italic>Haemophilus influenza</italic> type B vaccines.</p><p><sup>b</sup> Children receives both oral and injectable polio vaccines.</p><p><sup>c</sup> Administrated to pregnant women.</p></table-wrap-foot></table-wrap><p>Health facilities and outreach clinics are the main providers of immunization services in Nepal. Each district has about 3&#x02013;5 outreach clinics per village. In urban areas of the district, government health facilities, municipal clinics, private hospitals and private clinics deliver immunization services, in coordination and collaboration with the district health offices.</p><p>The objective of this study was to investigate changes in immunization coverage and equity gaps between 2001 and 2014, by using data from nationwide surveys.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Survey data</title><p>We used national survey data from Demographic and Health Surveys (DHS) for the years 2001,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> 2006<xref rid="R18" ref-type="bibr"><sup>18</sup></xref>and 2011<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> and the 2014 Multiple Indicator Cluster Survey (MICS).<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> Standardized sampling techniques were used in the four surveys to cover all areas of Nepal. The DHS and MICS methods apply different sampling frames, but all surveys are considered to be nationally representative, and can thus be considered comparable. Further details about the surveys can be found elsewhere.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> The 2014 MICS is the first nationally representative MICS performed in Nepal. DHS data has been accessed with permission from ORC Macro and MICS has been accessed and analysed with permission from the United Nations Children&#x02019;s Fund. From the surveys, we included data on children younger than 5&#x000a0;years.</p></sec><sec><title>Variables</title><p>For comparison reasons, we chose immunizations that were included in all four surveys. The variables comprised of: BCG vaccination at birth; three doses of polio vaccine at 1, 2 and 3&#x000a0;months of age; three doses of DPT vaccine at 1, 2 and 3&#x000a0;months of age; and measles vaccine at 9&#x000a0;months of age. To calculate fully immunized children, we created a composite variable for children who had received all of these vaccines at the age of 12&#x000a0;months.</p><p>To measure inequity, driven by socioeconomic determinants,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> we used the theoretical framework of the Commission on Social Determinants of Health. This framework emphasizes people&#x02019;s social position based on structural determinants as the main driver of inequity.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> To evaluate levels of inequity in immunization coverage, we stratified the immunization coverage data by socioeconomic determinants, including maternal education, area of residence, sex of child and family wealth. We did not include intermediary determinants, such as migration and maternal employment status. We dichotomized the determinants to detect differences between the most advantaged and the most disadvantaged populations. Maternal education was dichotomized as women with no education and women with a primary education or higher. Family areas of residence were divided between mountain areas and hill or terrain regions; the most disadvantaged families were those living in mountain areas. The families&#x02019; wealth index was constructed through principal component analysis of scores based on families&#x02019; ownership of durable assets, housing characteristics and access to services. From these indexes, we created wealth quintiles. These quintiles were then ranked from bottom to top, as poorest (first), poorer (second), middle (third), richer (fourth) and richest (fifth). To detect inequity between wealth quintiles, dichotomization was done as follows: the poor belonging to the poorest quintile, and the non-poor belonging to the other four quintiles. Even though the framework of the Commission on Social Determinants of Health considered ethnicity and caste as structural determinants, we were not able to include these variables in the analyses, since they were not captured in MICS.</p></sec><sec><title>Data analysis</title><p>For each vaccine we calculated the proportion of children who had received the recommended immunization for their age. For the composite variable, we calculated the proportion of children who had received all vaccination at the age of 12&#x000a0;months.</p><p>We calculated the slope index of inequality (SII) and the relative index of inequality (RII), which are two regression-based measures, for immunization coverage based on wealth quintiles. Both indexes take into account the whole socioeconomic distribution and remove variability in the size of socioeconomic groups as a source of variation in the magnitude of inequalities in health. SII is the absolute difference of immunization coverage between the richest and the poorest wealth quintile.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> RII is the ratio of the immunization coverage estimate between wealth quintiles, calculated on the basis of the systematic association between coverage estimate and the socioeconomic status for all wealth quintiles.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> An RII value of 1 indicates equity, while any value larger than 1 indicates inequity.</p><p>To analyse if there was an association between any of the socioeconomic determinants and immunization coverage, we used logistic regression models. We used univariate logistic regression to detect associations between coverage and socioeconomic variables, such as wealth quintile, geographic location, sex of child and maternal education. For those variables where we detected an association in the univariate logistic regression model, we did a multivariate logistic regression to adjust the effect of each socioeconomic variable on the immunization coverage. Results are presented as adjusted odds ratios (aORs). In this analysis, the sex of the child is an effect modifier of immunization coverage. Therefore, we checked whether sex of the child was associated with immunization coverage and found that no multicollinearity was detected during the initial analyses testing for effect modification.</p><p>We used SPSS version 20.0 (IBM, Chicago, United States of America) for the statistical analyses and a <italic>P</italic>-value of 0.05 was considered significant.</p></sec></sec><sec sec-type="results"><title>Results</title><p>After deleting survey responses for children with no information on immunization, we included 6931 (2001 DHS survey), 5783 (2006 DHS survey), 5306 (2011 DHS survey) and 3085 (2014 MICS survey) children in the analyses.</p><p>Overall, the surveys showed improvements in immunization coverage between 2001 and 2014 (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>), with significant increases in BCG, DPT and measles immunizations. Coverage of polio immunization did however show a declining trend over the same period. Also coverage of the second and third dose of DPT vaccine decreased in the latest survey in 2014 compared with the survey in 2011. The proportion of children being fully immunized at 12&#x000a0;months of age increased from an average of 68.8% (95% confidence interval, CI: 67.5&#x02013;70.1) in 2001 to an average of 88.0% (95% CI: 87.0&#x02013;89.0) in 2011, only to decline to an average of 82.4% (95% CI: 80.7&#x02013;84.0) in the most recent survey. The decline seen in the fully immunized coverage in 2014 can be attributed to reductions in polio and DPT coverage.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Immunization coverage in Nepal, 2001&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="118" span="1"/><col width="106" span="1"/><col width="92" span="1"/><col width="14" span="1"/><col width="113" span="1"/><col width="113" span="1"/><col width="14" span="1"/><col width="120" span="1"/><col width="92" span="1"/><col width="14" span="1"/><col width="106" span="1"/><col width="113" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Vaccine</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">2001 (DHS)<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">2006 (DHS)<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">2011 (DHS)<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">2014 (MICS)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of children<break/>immunized (no. children eligible<break/>for immunization)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Coverage, (%) (95% CI)</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of children<break/>immunized (no. children eligible<break/>for immunization)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Coverage, (%) <break/>(95% CI)</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of children<break/>immunized (no. children eligible<break/>for immunization)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Coverage, (%) (95% CI)</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">No. of children<break/>immunized (no. children eligible for immunization)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Coverage, (%) (95% CI)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">BCG (all children surviving first day of life)</td><td valign="top" align="center" rowspan="1" colspan="1">5300 (6471)</td><td valign="top" align="center" rowspan="1" colspan="1">81.9 (80.9&#x02013;82.8)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4756 (5252)</td><td valign="top" align="center" rowspan="1" colspan="1">90.6 (89.7&#x02013;91.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4705 (5054)</td><td valign="top" align="center" rowspan="1" colspan="1">93.3 (92.6&#x02013;94.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2832 (3070)</td><td valign="top" align="center" rowspan="1" colspan="1">92.2 (91.2&#x02013;93.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">First dose of oral polio (children older than 2&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">6100 (6211)</td><td valign="top" align="center" rowspan="1" colspan="1">98.2 (97.9&#x02013;98.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4902 (5058)</td><td valign="top" align="center" rowspan="1" colspan="1">96.9 (96.4&#x02013;97.4)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4647 (4909)</td><td valign="top" align="center" rowspan="1" colspan="1">94.7 (94.0&#x02013;95.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2790 (2939)</td><td valign="top" align="center" rowspan="1" colspan="1">94.9 (94.1&#x02013;95.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second dose of oral polio (children older than 3&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">5920 (6090)</td><td valign="top" align="center" rowspan="1" colspan="1">97.2 (96.8&#x02013;97.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4643 (4942)</td><td valign="top" align="center" rowspan="1" colspan="1">93.9 (93.2&#x02013;94.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4475 (4804)</td><td valign="top" align="center" rowspan="1" colspan="1">93.2 (92.4&#x02013;93.8)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2635 (2833)</td><td valign="top" align="center" rowspan="1" colspan="1">93.0 (92.0&#x02013;93.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Third dose of oral polio (children older than 4&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">5548 (5945)</td><td valign="top" align="center" rowspan="1" colspan="1">93.3 (92.7&#x02013;93.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4413 (4846)</td><td valign="top" align="center" rowspan="1" colspan="1">91.1 (90.2&#x02013;91.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4296 (4708)</td><td valign="top" align="center" rowspan="1" colspan="1">91.3 (90.4&#x02013;92.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2424 (2752)</td><td valign="top" align="center" rowspan="1" colspan="1">88.1 (86.8&#x02013;89.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">First dose of DPT (children older than 2&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">5126 (6210)</td><td valign="top" align="center" rowspan="1" colspan="1">82.6 (81.6&#x02013;83.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4625 (5058)</td><td valign="top" align="center" rowspan="1" colspan="1">91.4 (90.6&#x02013;92.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4634 (4909)</td><td valign="top" align="center" rowspan="1" colspan="1">94.4 (93.7&#x02013;95.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2736 (2928)</td><td valign="top" align="center" rowspan="1" colspan="1">93.4 (92.5&#x02013;94.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second dose of DPT (children older than 3&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">4709 (6094)</td><td valign="top" align="center" rowspan="1" colspan="1">77.3 (76.2&#x02013;78.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4407 (4974)</td><td valign="top" align="center" rowspan="1" colspan="1">88.6 (87.7&#x02013;89.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4460 (4804)</td><td valign="top" align="center" rowspan="1" colspan="1">92.8 (92.1&#x02013;93.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2563 (2827)</td><td valign="top" align="center" rowspan="1" colspan="1">90.7 (89.5&#x02013;91.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Third dose of DPT (children older than 4&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">4276 (5949)</td><td valign="top" align="center" rowspan="1" colspan="1">71.9 (70.7&#x02013;73.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4194 (4878)</td><td valign="top" align="center" rowspan="1" colspan="1">86.0 (85.0&#x02013;86.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4272 (4708)</td><td valign="top" align="center" rowspan="1" colspan="1">90.7 (89.9&#x02013;91.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2314 (2744)</td><td valign="top" align="center" rowspan="1" colspan="1">84.3 (82.9&#x02013;85.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Measles (children older than 9&#x000a0;months)</td><td valign="top" align="center" rowspan="1" colspan="1">3942 (5379)</td><td valign="top" align="center" rowspan="1" colspan="1">73.3 (72.1&#x02013;74.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3775 (4421)</td><td valign="top" align="center" rowspan="1" colspan="1">85.4 (84.3&#x02013;86.4)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3788 (4257)</td><td valign="top" align="center" rowspan="1" colspan="1">89.0 (88.0&#x02013;89.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2053 (2305)</td><td valign="top" align="center" rowspan="1" colspan="1">89.1 (87.7&#x02013;90.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fully immunized after 12 months (children older than 12 months)</td><td valign="top" align="center" rowspan="1" colspan="1">3547 (5154)</td><td valign="top" align="center" rowspan="1" colspan="1">68.8 (67.5&#x02013;70.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3460 (4232)</td><td valign="top" align="center" rowspan="1" colspan="1">81.8 (80.6&#x02013;82.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3551 (4035)</td><td valign="top" align="center" rowspan="1" colspan="1">88.0 (87.0&#x02013;89.0)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1718 (2084)</td><td valign="top" align="center" rowspan="1" colspan="1">82.4 (80.7&#x02013;84.0)</td></tr></tbody></table><table-wrap-foot><p>BCG: bacille Calmette&#x02013;Gu&#x000e9;rin; CI: confidence interval; DHS: Demographic and Health Survey; DPT; diphtheria&#x02013;pertussis&#x02013;tetanus&#x000a0;; MICS: Multiple Indicator Cluster Survey.</p><p>Note: Data from children younger than 5 years were included in the study.</p></table-wrap-foot></table-wrap><p>The equity in immunization coverage between wealth quintiles also improved over the study period (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). For children fully immunized at the age of 12&#x000a0;months, the absolute difference in coverage between the wealthiest quintile and the poorest quintile significantly decreased between 2001 and 2014, from an SII of 0.070 (95% CI: 0.061&#x02013;0.078) to an SII of 0.026 (95% CI: 0.013&#x02013;0.039). Improvements in equity were also seen for coverage in BCG vaccination, from a SII of 0.054 (95% CI: 0.047&#x02013;0.061) to anSII of 0.012 (95% CI: 0.005&#x02013;0.019); in DPT vaccination from 0.068 (95% CI: 0.060&#x02013;0.076) to 0.016 (95% CI: 0.005&#x02013;0.026); and in measles vaccination from 0.054 (95% CI: 0.046&#x02013;0.063) to 0.019 (95% CI: 0.009&#x02013;0.029). Likewise, the RII improved for these vaccines (<xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). The equity for polio vaccination coverage did not improve over the study period. However, the SII and RII were already low in 2001: 0.017 (95% CI: 0.012&#x02013;0.022) and 1.02, respectively, and were similar in 2014 (SII: 0.017; 95% CI: 0.008&#x02013;0.027 and RII: 1.02). The decrease in polio vaccination coverage during the study period did not seem to affect equity, since the decrease was similar in all wealth quintiles.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Inequalities in immunization coverage by wealth quintiles, Nepal 2001 and 2014</title></caption><table frame="hsides" rules="groups"><col width="83" span="1"/><col width="70" span="1"/><col width="99" span="1"/><col width="42" span="1"/><col width="14" span="1"/><col width="70" span="1"/><col width="99" span="1"/><col width="42" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Vaccination, by wealth quintiles</th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">2001<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">2014<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Coverage,<break/>(%)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">SII (95% CI)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">RII</th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Coverage,<break/>(%)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">SII (95% CI)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">RII</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Fully immunized<sup>a</sup></bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Richest</td><td valign="top" align="center" rowspan="1" colspan="1">84.8</td><td rowspan="5" valign="top" align="center" colspan="1">0.070<break/>(0.061&#x02013;0.078)</td><td rowspan="5" valign="top" align="center" colspan="1">1.13</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">86.0</td><td rowspan="5" valign="top" align="center" colspan="1">0.026<break/>(0.013&#x02013;0.039)</td><td rowspan="5" valign="top" align="center" colspan="1">1.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fourth</td><td valign="top" align="center" rowspan="1" colspan="1">76.6</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">85.6</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">66.4</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">83.0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second</td><td valign="top" align="center" rowspan="1" colspan="1">65.9</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">83.6</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poorest</td><td valign="top" align="center" rowspan="1" colspan="1">58.6</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">77.9</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>BCG</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Richest</td><td valign="top" align="center" rowspan="1" colspan="1">92.2</td><td rowspan="5" valign="top" align="center" colspan="1">0.054<break/>(0.047&#x02013;0.061)</td><td rowspan="5" valign="top" align="center" colspan="1">1.08</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">94.4</td><td rowspan="5" valign="top" align="center" colspan="1">0.012<break/>(0.005&#x02013;0.019)</td><td rowspan="5" valign="top" align="center" colspan="1">1.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fourth</td><td valign="top" align="center" rowspan="1" colspan="1">87.2</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">95.5</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">82.6</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">95.2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second</td><td valign="top" align="center" rowspan="1" colspan="1">79.3</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">94.4</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poorest</td><td valign="top" align="center" rowspan="1" colspan="1">73.9</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">91.2</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Three doses of oral polio</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Richest</td><td valign="top" align="center" rowspan="1" colspan="1">97.5</td><td rowspan="5" valign="top" align="center" colspan="1">0.017<break/>(0.012&#x02013;0.022)</td><td rowspan="5" valign="top" align="center" colspan="1">1.02</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">92.8</td><td rowspan="5" valign="top" align="center" colspan="1">0.017<break/>(0.008&#x02013;0.027)</td><td rowspan="5" valign="top" align="center" colspan="1">1.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fourth</td><td valign="top" align="center" rowspan="1" colspan="1">93.6</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">91.2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">94.3</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">87.7</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second</td><td valign="top" align="center" rowspan="1" colspan="1">92.2</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">87.7</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poorest</td><td valign="top" align="center" rowspan="1" colspan="1">89.6</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">85.6</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Three doses of DPT</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Richest</td><td valign="top" align="center" rowspan="1" colspan="1">88.4</td><td rowspan="5" valign="top" align="center" colspan="1">0.068 <break/>(0.060&#x02013;0.076)</td><td rowspan="5" valign="top" align="center" colspan="1">1.11</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">89.3</td><td rowspan="5" valign="top" align="center" colspan="1">0.016<break/>(0.005&#x02013;0.026)</td><td rowspan="5" valign="top" align="center" colspan="1">1.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fourth</td><td valign="top" align="center" rowspan="1" colspan="1">78.8</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">86.7</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">68.7</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">83.0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second</td><td valign="top" align="center" rowspan="1" colspan="1">68.7</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">84.5</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poorest</td><td valign="top" align="center" rowspan="1" colspan="1">62.8</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">82.0</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Measles</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Richest</td><td valign="top" align="center" rowspan="1" colspan="1">73.9</td><td rowspan="5" valign="top" align="center" colspan="1">0.054<break/>(0.046&#x02013;0.063)</td><td rowspan="5" valign="top" align="center" colspan="1">1.09</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">93.2</td><td rowspan="5" valign="top" align="center" colspan="1">0.019<break/>(0.009&#x02013;0.029)</td><td rowspan="5" valign="top" align="center" colspan="1">1.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fourth</td><td valign="top" align="center" rowspan="1" colspan="1">67.0</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">91.1</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">59.3</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">90.9</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Second</td><td valign="top" align="center" rowspan="1" colspan="1">60.0</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">89.4</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poorest</td><td valign="top" align="center" rowspan="1" colspan="1">54.3</td><td valign="top" colspan="1" align="left" rowspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">85.9</td></tr></tbody></table><table-wrap-foot><p>BCG: bacille Calmette&#x02013;Gu&#x000e9;rin; CI: confidence interval; DPT; diphtheria&#x02013;pertussis&#x02013;tetanus; RII: relative index of inequality; SII: slope index of inequality.</p><p><sup>a</sup> Children who had received BCG vaccine, three doses of diphtheria&#x02013;tetanus&#x02013;pertussis vaccine, three doses of polio vaccine and measles vaccines were categorized as fully immunized.</p><p>Notes: SII is the absolute difference of immunization coverage between the richest and the poorest wealth quintile.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> RII is the ratio of the immunization coverage estimate between wealth quintiles, calculated on the basis of the systematic association between coverage estimate and the socioeconomic status for all wealth quintiles. </p></table-wrap-foot></table-wrap><p>For all wealth quintiles, the proportion of children who had received all doses of immunization at the age of 12&#x000a0;months increased during the study period. However, the improvement in coverage was much greater in the poorest quintiles (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). For the poorest quintile, coverages of BCG, DPT and measles immunizations improved over time (<xref ref-type="table" rid="T4">Table&#x000a0;4</xref>). Only coverage of complete polio immunization in the poorest quintiles displays a different pattern with only a minor increase between 2001 and 2006, and then a stagnant situation. The decreased inequity by wealth in immunization coverage was maintained when adjusting for other socioeconomic factors. In a multivariate regression model, we detected a risk reduction for the poorest children (1st quintile) not being fully immunized between 2001 and 2014. In 2001, the poorest children were 1.5-fold less likely not to be fully immunized (aOR: 1.56; 95% CI: 95% 1.37&#x02013;1.79) compared to children from the other quintiles. In 2014, the likelihood of not being fully immunized was not significant (aOR: 1.17; 95% CI: 0.93&#x02013;1.46; <xref ref-type="table" rid="T5">Table&#x000a0;5</xref>). The analysis also revealed a similar trend for mother&#x02019;s education level. Children of non-educated mothers were four times more likely not to be fully immunized in 2001 (aOR: 4.13; 95% CI: 3.52&#x02013;4.85), which was reduced to 1.5-fold in 2014 (aOR: 1.53; 95% CI: 1.20&#x02013;1.96; <xref ref-type="table" rid="T5">Table&#x000a0;5</xref>).</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Children fully immunized at 12&#x000a0;months of age, by wealth quintiles, Nepal, 2001 and 2014</p></caption><p>Notes: Fully immunized children is a composite variable for children who had received all the scheduled vaccines (bacille Calmette&#x02013;Gu&#x000e9;rin, three doses of polio at 1, 2 and 3&#x000a0;months of age, three doses of pentavalent at 1, 2 and 3&#x000a0;months of age and measles at 9&#x000a0;months). The first wealth quintile represents the poorest and the fifth quintile the wealthiest.</p><graphic xlink:href="BLT.16.178327-F1"/></fig><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Proportion of children in the poorest quintile not vaccinated, Nepal, 2001&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="54" span="1"/><col width="99" span="1"/><col width="99" span="1"/><col width="14" span="1"/><col width="99" span="1"/><col width="99" span="1"/><col width="14" span="1"/><col width="106" span="1"/><col width="106" span="1"/><col width="14" span="1"/><col width="113" span="1"/><col width="106" span="1"/><col width="12" span="1"/><col width="104" span="1"/><col width="102" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Year</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Full immunization <break/>(at 12 months of age)<hr/></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">BCG <break/>(at birth)<hr/></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">DTP3 <break/>(at 4&#x000a0;months of age)<hr/></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Oral polio third dose <break/>(at 4&#x000a0;months of age)<hr/></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Measles<break/>(at 10 months of age)<hr/></th></tr><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of nonimmunized children (eligible children)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Proportion, (%)<break/>(95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of nonimmunized children (eligible children)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Proportion, (%)<break/>(95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of nonimmunized children (eligible children)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Proportion, (%) <break/>(95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of nonimmunized children (eligible children)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Proportion, (%)<break/>(95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No. of immunized children (eligible children)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Proportion, (%)<break/>(95% CI)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2001</td><td valign="top" align="center" rowspan="1" colspan="1">556 (1342)</td><td valign="top" align="center" rowspan="1" colspan="1">41.4 (38.8&#x02013;44.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">425 (1632)</td><td valign="top" align="center" rowspan="1" colspan="1">26.0 (23.9&#x02013;28.2)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">562 (1510)</td><td valign="top" align="center" rowspan="1" colspan="1">37.2 (34.8&#x02013;39.7)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">158 (1516)</td><td valign="top" align="center" rowspan="1" colspan="1">10.4 (8.9&#x02013;12.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">483 (1&#x02009;388)</td><td valign="top" align="center" rowspan="1" colspan="1">34.8 (32.3&#x02013;37.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2006</td><td valign="top" align="center" rowspan="1" colspan="1">322 (1075)</td><td valign="top" align="center" rowspan="1" colspan="1">30.0 (27.2&#x02013;32.8)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">253 (1328)</td><td valign="top" align="center" rowspan="1" colspan="1">19.1 (17.0&#x02013;21.3)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">343 (1233)</td><td valign="top" align="center" rowspan="1" colspan="1">27.8 (25.3&#x02013;30.4)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">230 (1233)</td><td valign="top" align="center" rowspan="1" colspan="1">18.7 (16.5&#x02013;20.9)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">285 (1&#x02009;121)</td><td valign="top" align="center" rowspan="1" colspan="1">25.4 (20.9&#x02013;28.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">228 (1273)</td><td valign="top" align="center" rowspan="1" colspan="1">17.9 (15.8&#x02013;20.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">204 (1578)</td><td valign="top" align="center" rowspan="1" colspan="1">12.9 (11.3&#x02013;14.7)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">236 (1467)</td><td valign="top" align="center" rowspan="1" colspan="1">16.1 (14.2&#x02013;18.1)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">228 (1467)</td><td valign="top" align="center" rowspan="1" colspan="1">15.5 (13.7&#x02013;17.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">223 (1&#x02009;339)</td><td valign="top" align="center" rowspan="1" colspan="1">16.7 (14.7&#x02013;18.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2014</td><td valign="top" align="center" rowspan="1" colspan="1">165 (747)</td><td valign="top" align="center" rowspan="1" colspan="1">22.1 (19.1&#x02013;25.2)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">96 (1097)</td><td valign="top" align="center" rowspan="1" colspan="1">8.8 (7.1&#x02013;10.6)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">177 (984)</td><td valign="top" align="center" rowspan="1" colspan="1">18.0 (15.6&#x02013;20.5)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">142 (988)</td><td valign="top" align="center" rowspan="1" colspan="1">14.4 (12.2&#x02013;16.7)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">119 (841)</td><td valign="top" align="center" rowspan="1" colspan="1">14.1 (11.9&#x02013;16.7)</td></tr></tbody></table><table-wrap-foot><p>BCG: bacille Calmette&#x02013;Gu&#x000e9;rin; CI: confidence interval; DPT3; third dose of diphtheria&#x02013;pertussis&#x02013;tetanus.</p></table-wrap-foot></table-wrap><table-wrap id="T5" orientation="portrait" position="float"><label>Table 5</label><caption><title>Likelihood of children aged 12&#x000a0;months not being fully immunized, Nepal, 2001&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="96" span="1"/><col width="121" span="1"/><col width="113" span="1"/><col width="120" span="1"/><col width="106" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th><th colspan="4" valign="top" align="center" scope="colgroup" rowspan="1">aOR (95% CI)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">2001</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">2006</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">2011</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">2014</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Wealth</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nonpoor<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Poor<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1">1.56 (1.37&#x02013;1.79)</td><td valign="top" align="center" rowspan="1" colspan="1">2.05 (1.71&#x02013;2.46)</td><td valign="top" align="center" rowspan="1" colspan="1">1.70 (1.44&#x02013;2.22)</td><td valign="top" align="center" rowspan="1" colspan="1">1.17 (0.93&#x02013;1.46)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Education</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Literate</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Illiterate</td><td valign="top" align="center" rowspan="1" colspan="1">4.13 (3.52&#x02013;4.85)</td><td valign="top" align="center" rowspan="1" colspan="1">3.12 (2.60&#x02013;3.75)</td><td valign="top" align="center" rowspan="1" colspan="1">3.20 (2.57&#x02013;4.00)</td><td valign="top" align="center" rowspan="1" colspan="1">1.53 (1.20&#x02013;1.96)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Residence</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hill or terrain</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mountain</td><td valign="top" align="center" rowspan="1" colspan="1">1.03 (0.82&#x02013;1.30)</td><td valign="top" align="center" rowspan="1" colspan="1">1.55 (1.20&#x02013;2.01)</td><td valign="top" align="center" rowspan="1" colspan="1">0.75 (0.57&#x02013;0.98)</td><td valign="top" align="center" rowspan="1" colspan="1">1.47 (1.14&#x02013;1.90)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Urban</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rural</td><td valign="top" align="center" rowspan="1" colspan="1">1.13 (0.85&#x02013;1.51)</td><td valign="top" align="center" rowspan="1" colspan="1">0.63 (0.48&#x02013;0.82)</td><td valign="top" align="center" rowspan="1" colspan="1">0.89 (0.68&#x02013;1.17)</td><td valign="top" align="center" rowspan="1" colspan="1">1.41 (0.96&#x02013;2.08)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sex</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Boys</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td><td valign="top" align="center" rowspan="1" colspan="1">Ref.</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Girls</td><td valign="top" align="center" rowspan="1" colspan="1">1.01 (0.87&#x02013;1.12)</td><td valign="top" align="center" rowspan="1" colspan="1">1.02 (0.99&#x02013;1.26)</td><td valign="top" align="center" rowspan="1" colspan="1">1.12 (0.89&#x02013;1.27)</td><td valign="top" align="center" rowspan="1" colspan="1">1.07 (0.92&#x02013;1.23)</td></tr></tbody></table><table-wrap-foot><p>aOR: adjusted odds ratio; CI: confidence interval; Ref.: reference group.</p><p><sup>a</sup> Including children in the 2nd to 5th wealth quintiles.</p><p><sup>b</sup> Including children in the first wealth quintile.</p><p>Notes: We adjusted the multivariate logistic regression for sex of child. Children who had received bacille Calmette&#x02013;Gu&#x000e9;rin vaccine, three doses of diphtheria&#x02013;tetanus&#x02013;pertussis vaccine, three doses of polio vaccine and measles vaccines were categorized as fully immunized.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>This study shows that immunization coverage of Nepalese children aged 12&#x000a0;months or younger has improved significantly between 2001 and 2014; an increase that has been accompanied by improved equity. The improved coverage can be attributed to the concentrated efforts of the Nepalese government in collaboration with nongovernmental organizations, which have focused on hard-to-reach and disadvantaged populations with low immunization coverage. Improvements have been the greatest in the poorer and less educated populations, resulting in a decreased equity gap. This achievement is important since the National Immunization Programme strives to achieve herd immunity within a population.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> To accomplish such immunity, wide population coverage is needed and failure to reach certain populations might leave them susceptible to vaccine-preventable disease outbreaks.</p><p>The results show a setback in polio vaccination coverage. The coverage of the first dose of oral polio vaccine decreased over the study period, from a high level in 2001, to significantly lower between 2001 and 2014. This decrease might be because people may not perceive polio as such a great threat anymore and therefore think immunization is no longer necessary. In 1996, the government initiated a polio eradication programme, which conducted national immunization days targeting all children younger than 5&#x000a0;years with two doses of oral polio vaccine. In subsequent years, Nepal implemented all four strategies required for polio eradication: strengthening routine immunization, supplementary immunization activities, surveillance and outbreak response. The last person infected with indigenous wild polio virus was detected in 1999 and Nepal was declared to have eradicated polio in 2000.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> Between 2000 and 2010, 30 individuals in the country have been detected with imported wild polio virus and in the past 5&#x000a0;years, Nepal has been free of polio.</p><p>Previous studies conducted in the WHO South-East Asian Region, have examined the relationship between various equity parameters and immunization coverage. In line with our results, a study from Cambodia showed that socioeconomic factors were most strongly associated with decreased access to immunization services, compared to other factors such as gender or rural/urban location.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Furthermore, social distance, that is the distance a person is from health care in terms of acceptability and affordability, was discussed as the main determinant of immunization access as compared to geographical distance.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Our study confirms that geographical location, or the urban/rural divide, does not contribute to differences in immunization coverage. Another study from Pakistan found similar inequities when examining the uptake of measles vaccination.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> Children who lived further than 5&#x000a0;km away from vaccination facilities, had poor roofing, parents with a poorly paid job or mothers who were uneducated, were less likely to be vaccinated in both urban and rural areas.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> Finally, a systematic review of studies done in India found an association between immunization coverage and the sex of the child, birth order, residence, household wealth, parental education and access to health-care services.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> In our study, the sex of the child did not significantly influence coverage. Girls were only slightly less likely to be fully immunized at the age of 12 months compared to boys, a difference that did not show significance at any time point after adjustment for other socioeconomic determinants.</p><p>This study has several limitations. First, we used data from two different surveys with different survey methods, which could limit the comparison between time periods. For example, DHS and MICS define and calculate wealth index differently. Second, the absence of ethnicity data in MICS meant that we could not study ethnicity as a social determinant of inequity for immunization coverage. Third, the MICS sample size was smaller than in three previous DHS. Fourth, to calculate SII and RII, the methods require a somewhat even distribution of inequity in the groups compared, otherwise differences in the poorest or richest quintiles compared to the overall population can be hidden and the results misleading.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> For our data, there was a large inequity between poorest and richest quintiles, which masked the magnitude of those inequities when calculating the SII. However, using a logistic regression model, we were able to detect these inequities. Fifth, respondent bias can never be ruled out. Respondents might have a willingness to please, which would result in overreporting of immunization coverage. However, this bias can be considered systematic and would not affect the improvement of equity in relation to coverage. Despite these limitations, the survey data allow for comparisons over time, especially since the definition of dependent variables, if the child received a certain vaccine or not, is easy to define, measure and compare.</p><p>This study from Nepal demonstrates how directed interventions for the most disadvantaged people can be an important strategy to reach universal immunization coverage and also to help reach Target 3.8 of the sustainable development goals.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> Part of this target states that all people should have the right to vaccination, which is also one of the aims of the Human Right to Health Movement.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Even though the increase in overall immunization coverage addressed the equity gap, inequities still exist in Nepal. However, the trend in the past 15 years is promising and indicates the possibility that Nepal will be able to achieve universal immunization coverage.</p></sec></body><back><ack><title>Funding:</title><p>The United Nations Children's Fund, Nepal, funded the study.</p></ack><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Brearley</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Eggers</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Steinglass</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vandelaer</surname>
<given-names>J</given-names></string-name>. <article-title>Applying an equity lens in the decade of vaccines.</article-title>
<source>Vaccine</source>. <year>2013</year>
<month>4</month>
<day>18</day>;<volume>31</volume>
<issue>Suppl 2</issue>:<fpage>B103</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.11.088</pub-id><pub-id pub-id-type="pmid">23598470</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Bryce</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Black</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Walker</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bhutta</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Lawn</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Steketee</surname>
<given-names>RW</given-names></string-name>. <article-title>Can the world afford to save the lives of 6 million children each year?</article-title>
<source>Lancet</source>. <year>2005</year>
<month>6</month>
<day>25</day>;<volume>365</volume>(<issue>9478</issue>):<fpage>2193</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)66777-3</pub-id><pub-id pub-id-type="pmid">15978927</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="book"><article-title>Global vaccination action plan 2011-2020</article-title>. <publisher-loc>Geneva</publisher-loc>: <collab>World Health Organization</collab>; <year>2012</year>.</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Delamonica</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Minujin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gulaid</surname>
<given-names>J</given-names></string-name>. <article-title>Monitoring equity in immunization coverage.</article-title>
<source>Bull World Health Organ</source>. <year>2005</year>
<month>5</month>;<volume>83</volume>(<issue>5</issue>):<fpage>384</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">15976881</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>M&#x000e5;lqvist</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Trygg</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Selling</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Thomsen</surname>
<given-names>S</given-names></string-name>. <article-title>Targeted interventions for improved equity in maternal and child health in low- and middle-income settings: a systematic review and meta-analysis.</article-title>
<source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>6</issue>):<fpage>e66453</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0066453</pub-id><pub-id pub-id-type="pmid">23840474</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Victora</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Barros</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Axelson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bhutta</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Chopra</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fran&#x000e7;a</surname>
<given-names>GV</given-names></string-name>, <etal>et al.</etal>
<article-title>How changes in coverage affect equity in maternal and child health interventions in 35 Countdown to 2015 countries: an analysis of national surveys.</article-title>
<source>Lancet</source>. <year>2012</year>
<month>9</month>
<day>29</day>;<volume>380</volume>(<issue>9848</issue>):<fpage>1149</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)61427-5</pub-id><pub-id pub-id-type="pmid">22999433</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="book"><string-name><surname>Waisbord</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Larson</surname>
<given-names>H</given-names></string-name>. <source>Why invest in communication for immunization: evidence and lessons learned.</source>
<publisher-loc>Baltimore and New York</publisher-loc>: <publisher-name>Johns Hopkins Bloomberg School of Public Health, Center for Communication Programs and the United Nations Children&#x02019;s Fund</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Kc</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bhandari</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pradhan</surname>
<given-names>YV</given-names></string-name>, <string-name><surname>Kc</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>Upreti</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Thapa</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal>
<article-title>State of maternal, newborn and child health programmes in Nepal: what may a continuum of care model mean for more effective and efficient service delivery?</article-title>
<source>J Nepal Health Res Counc</source>. <year>2011</year>
<month>10</month>;<volume>9</volume>(<issue>2</issue>):<fpage>92</fpage>. <pub-id pub-id-type="pmid">22929837</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="book"><string-name><surname>Vaillancourt</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pokhrel</surname>
<given-names>S</given-names></string-name>. <source>Aid effectiveness in Nepal health sector: accomplishments to date and measurement challenges.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>International Health Partnership (IHP+)</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="book"><string-name><surname>David Daniels</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Thapa</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Reveillon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pathak</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Baral</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hamid</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal>
<source>Nepal health sector programme II (NHSP II).</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Health and Education Advice and Resource Team</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="book"><string-name><surname>Foster</surname>
<given-names>MJQ</given-names></string-name>, <string-name><surname>Regmi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Shrestha</surname>
<given-names>B</given-names></string-name>. <source>Review of Nepal health sector programme: a background document for the mid-term review.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Mick Foster Economics Ltd, Development Consultancy Center</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="book"><source>National communication strategy on maternal, newborn, child health 2011&#x02013;2016.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health and Population, National Health Education, Information and Communication Center</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="book"><source>Nepal health sector programme 2004&#x02013;2009.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health and Population</publisher-name>; <year>2004</year>.</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="book"><source>Nepal health sector program implementation plan- I.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health and Population</publisher-name>; <year>2004</year>.</mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="book"><source>Expanded programme on immunization 1996.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Child Health Division, Ministry of Health</publisher-name>; <year>1996</year>.</mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="book"><source>National immunization program: reaching every child: comprehensive multi-year plan 2017&#x02013;2022.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health, Child Health Division</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="book"><source>Nepal demographic and health survey 2001. Kathmandu: Ministry of Health and Population.</source>
<publisher-loc>Calverton</publisher-loc>: <publisher-name>New ERA, and ICF International</publisher-name>; <year>2002</year>.</mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="book"><source>Nepal demographic and health survey 2006.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health and Population, New ERA, and ICF International</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="book"><source>Nepal demographic and health survey 2011.</source>
<publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Ministry of Health and Population, New ERA, and ICF International</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="book"><source>Nepal multiple indicator cluster survey 2014</source> [<comment>Key Findings and Tables</comment>]. <publisher-loc>Kathmandu</publisher-loc>: <publisher-name>Central Bureau of Statistics/Government of Nepal, UNICEF</publisher-name>; <year>2015</year>.</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="web">Commision on Social Determinants of Health (CSDH): background 3: key concepts. Geneva: World Health Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/social_determinants/en/">http://www.who.int/social_determinants/en/</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2014 March 1]. </mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Mackenbach</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Kunst</surname>
<given-names>AE</given-names></string-name>. <article-title>Measuring the magnitude of socio-economic inequalities in health: an overview of available measures illustrated with two examples from Europe.</article-title>
<source>Soc Sci Med</source>. <year>1997</year>
<month>3</month>;<volume>44</volume>(<issue>6</issue>):<fpage>757</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0277-9536(96)00073-1</pub-id><pub-id pub-id-type="pmid">9080560</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Chan Soeung</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grundy</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Duncan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thor</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bilous</surname>
<given-names>JB</given-names></string-name>. <article-title>From reaching every district to reaching every community: analysis and response to the challenge of equity in immunization in Cambodia.</article-title>
<source>Health Policy Plan</source>. <year>2013</year>
<month>8</month>;<volume>28</volume>(<issue>5</issue>):<fpage>526</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/heapol/czs096</pub-id><pub-id pub-id-type="pmid">23048124</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Mitchell</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Andersson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ansari</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Omer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Soberanis</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Cockcroft</surname>
<given-names>A</given-names></string-name>. <article-title>Equity and vaccine uptake: a cross-sectional study of measles vaccination in Lasbela District, Pakistan.</article-title>
<source>BMC Int Health Hum Rights</source>. <year>2009</year>
<month>10</month>
<day>14</day>;<volume>9</volume>
<issue>Suppl 1</issue>:<fpage>S7</fpage>. <pub-id pub-id-type="doi">10.1186/1472-698X-9-S1-S7</pub-id><pub-id pub-id-type="pmid">19828065</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Mathew</surname>
<given-names>JL</given-names></string-name>. <article-title>Inequity in childhood immunization in India: a systematic review.</article-title>
<source>Indian Pediatr</source>. <year>2012</year>
<month>3</month>;<volume>49</volume>(<issue>3</issue>):<fpage>203</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1007/s13312-012-0063-z</pub-id><pub-id pub-id-type="pmid">22484740</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="web">Resolution A/RES/70/1. Transforming our world: the 2030 agenda for sustainable development. In: Seventieth United Nations General Assembly, New York, 25 September 2015. New York: United Nations; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&#x00026;Lang=E">http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&#x00026;Lang=E</ext-link> [cited 2017 Jan 23].</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="book"><string-name><surname>Chapman</surname>
<given-names>A</given-names></string-name>. <source>Global health, human rights and the challenge of neoliberal policies.</source>
<publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>; <year>2016</year> p. <fpage>85</fpage>
<pub-id pub-id-type="doi">10.1017/CBO9781316104576</pub-id></mixed-citation></ref></ref-list></back></article>